An interview with Deputy Health Minister Maciej Miłkowski about possible changes in access to early breast cancer treatment.
Maciej Miłkowski:
- For July, we plan to make some changes
- We have several therapies in the reimbursement process, including, among others, two indications of pembrolizumab
- A total of five therapies planned for the July list will be negotiated in May
